{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:31:22Z","timestamp":1769560282485,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162121"],"award-info":[{"award-number":["PJT-162121"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["EGID-3779"],"award-info":[{"award-number":["EGID-3779"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Strategies for treating progressive multiple sclerosis (MS) remain limited. Here, we found that miR-145-5p is overabundant uniquely in chronic lesion tissues from secondary progressive MS patients. We induced both acute and chronic demyelination in miR-145 knockout mice to determine its contributions to remyelination failure. Following acute demyelination, no advantage to miR-145 loss could be detected. However, after chronic demyelination, animals with miR-145 loss demonstrated increased remyelination and functional recovery, coincident with altered presence of astrocytes and microglia within the corpus callosum relative to wild-type animals. This improved response in miR-145 knockout animals coincided with a pathological upregulation of miR-145-5p in wild-type animals with chronic cuprizone exposure, paralleling human chronic lesions. Furthermore, miR-145 overexpression specifically in oligodendrocytes (OLs) severely stunted differentiation and negatively impacted survival. RNAseq analysis showed altered transcriptome in these cells with downregulated major pathways involved in myelination. Our data suggest that pathological accumulation of miR-145-5p is a distinctive feature of chronic demyelination and is strongly implicated in the failure of remyelination, possibly due to the inhibition of OL differentiation together with alterations in other glial cells. This is mirrored in chronic MS lesions, and thus miR-145-5p serves as a potential relevant therapeutic target in progressive forms of MS.<\/jats:p>","DOI":"10.1038\/s42003-024-06513-x","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T13:04:46Z","timestamp":1720098286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2372-2626","authenticated-orcid":false,"given":"Samantha F.","family":"Kornfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Yaworski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"De Repentigny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Zandee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-0580","authenticated-orcid":false,"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-7310","authenticated-orcid":false,"given":"Rashmi","family":"Kothary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"6513_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","volume":"19","author":"R Li","year":"2018","unstructured":"Li, R., Patterson, K. R. & Bar-Or, A. Reassessing B cell contributions in multiple sclerosis. Nat. Immunol. 19, 696\u2013707 (2018).","journal-title":"Nat. Immunol."},{"key":"6513_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"A Compston","year":"2002","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 359, 1221\u20131231 (2002).","journal-title":"Lancet"},{"key":"6513_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","volume":"52","author":"SL Hauser","year":"2006","unstructured":"Hauser, S. L. & Oksenberg, J. R. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 52, 61\u201376 (2006).","journal-title":"Neuron"},{"key":"6513_CR4","first-page":"109","volume":"7","author":"L Sedal","year":"2017","unstructured":"Sedal, L., Winkel, A., Laing, J., Law, L. Y. & McDonald, E. Current concepts in multiple sclerosis therapy. Degener. Neurol. Neuromuscul. Dis. 7, 109\u2013125 (2017).","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"6513_CR5","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.clinthera.2014.08.006","volume":"36","author":"MD Carrithers","year":"2014","unstructured":"Carrithers, M. D. Update on disease-modifying treatments for multiple sclerosis. Clin. Ther. 36, 1938\u20131945 (2014).","journal-title":"Clin. Ther."},{"key":"6513_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13311-012-0162-5","volume":"10","author":"HL Atkins","year":"2013","unstructured":"Atkins, H. L. & Freedman, M. S. Hematopoietic stem cell therapy for multiple sclerosis: Top 10 lessons learned. Neurotherapeutics 10, 68\u201376 (2013).","journal-title":"Neurotherapeutics"},{"key":"6513_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jamaneurol.2016.5867","volume":"74","author":"PA Muraro","year":"2017","unstructured":"Muraro, P. A. et al. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurol. 74, 459\u2013469 (2017).","journal-title":"JAMA Neurol."},{"key":"6513_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8536785","volume":"2019","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Autologous mesenchymal stem cell transplantation in multiple sclerosis: A meta-analysis. Stem Cells Int. 2019, 8536785 (2019).","journal-title":"Stem Cells Int."},{"key":"6513_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2990.2007.00805.x","volume":"33","author":"R Patani","year":"2007","unstructured":"Patani, R., Balaratnam, M., Vora, A. & Reynolds, R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 33, 277\u2013287 (2007).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"6513_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ana.410330203","volume":"33","author":"JW Prineas","year":"1993","unstructured":"Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R. & Cho, E. S. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33, 137\u2013151 (1993).","journal-title":"Ann. Neurol."},{"key":"6513_CR11","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/brain\/awl217","volume":"129","author":"P Patrikios","year":"2006","unstructured":"Patrikios, P. et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165\u20133172 (2006).","journal-title":"Brain"},{"key":"6513_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrn2797","volume":"11","author":"KA Nave","year":"2010","unstructured":"Nave, K. A. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 11, 275\u2013283 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"6513_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","volume":"125","author":"A Boyd","year":"2013","unstructured":"Boyd, A., Zhang, H. & Williams, A. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol. 125, 841\u2013859 (2013).","journal-title":"Acta Neuropathol."},{"key":"6513_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/135245859700300221","volume":"3","author":"G Wolswijk","year":"1997","unstructured":"Wolswijk, G. Oligodendrocyte precursor cells in chronic multiple sclerosis lesions. Mult. Scler. 3, 168\u2013169 (1997).","journal-title":"Mult. Scler."},{"key":"6513_CR15","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann, T. et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131, 1749\u20131758 (2008).","journal-title":"Brain"},{"key":"6513_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00401-017-1741-7","volume":"134","author":"GJ Duncan","year":"2017","unstructured":"Duncan, G. J. et al. Myelin regulatory factor drives remyelination in multiple sclerosis. Acta Neuropathol. 134, 403\u2013422 (2017).","journal-title":"Acta Neuropathol."},{"key":"6513_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.expneurol.2013.10.017","volume":"251","author":"DE Harlow","year":"2014","unstructured":"Harlow, D. E. & Macklin, W. B. Inhibitors of myelination: ECM changes, CSPGs and PTPs. Exp. Neurol. 251, 39\u201346 (2014).","journal-title":"Exp. Neurol."},{"key":"6513_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839\u2013855 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"6513_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ana.23599","volume":"72","author":"LW Lau","year":"2012","unstructured":"Lau, L. W. et al. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann. Neurol. 72, 419\u2013432 (2012).","journal-title":"Ann. Neurol."},{"key":"6513_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/NEN.0b013e31820937e4","volume":"70","author":"JE Tobin","year":"2011","unstructured":"Tobin, J. E., Xie, M., Le, T. Q., Song, S. K. & Armstrong, R. C. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging. J. Neuropathol. Exp. Neurol. 70, 157\u2013165 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"6513_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/jcp.29910","volume":"236","author":"SF Kornfeld","year":"2021","unstructured":"Kornfeld, S. F., Cummings, S. E., Fathi, S., Bonin, S. R. & Kothary, R. MiRNA-145-5p prevents differentiation of oligodendrocyte progenitor cells by regulating expression of myelin gene regulatory factor. J. Cell Physiol. 236, 991\u20131012 (2021).","journal-title":"J. Cell Physiol."},{"key":"6513_CR22","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/brain\/awp300","volume":"132","author":"A Junker","year":"2009","unstructured":"Junker, A. et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132, 3342\u20133352 (2009).","journal-title":"Brain"},{"key":"6513_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/AN20120062","volume":"4","author":"N Hibbits","year":"2012","unstructured":"Hibbits, N., Yoshino, J., Le, T. Q. & Armstrong, R. C. Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 4, 393\u2013408 (2012).","journal-title":"ASN Neuro"},{"key":"6513_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.expneurol.2016.06.033","volume":"283","author":"CB Bai","year":"2016","unstructured":"Bai, C. B. et al. A mouse model for testing remyelinating therapies. Exp. Neurol. 283, 330\u2013340 (2016).","journal-title":"Exp. Neurol."},{"key":"6513_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.devcel.2013.05.013","volume":"25","author":"T Czopka","year":"2013","unstructured":"Czopka, T., Ffrench-Constant, C. & Lyons, D. A. Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo. Dev. Cell 25, 599\u2013609 (2013).","journal-title":"Dev. Cell"},{"key":"6513_CR26","doi-asserted-by":"publisher","first-page":"e10480","DOI":"10.1371\/journal.pone.0010480","volume":"5","author":"BS Letzen","year":"2010","unstructured":"Letzen, B. S. et al. MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells. PLoS ONE 5, e10480 (2010).","journal-title":"PLoS ONE"},{"key":"6513_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10883","volume":"7","author":"C Zhao","year":"2016","unstructured":"Zhao, C. et al. Dual regulatory switch through interactions of Tcf7l2\/Tcf4 with stage-specific partners propels oligodendroglial maturation. Nat. Commun. 7, 10883 (2016).","journal-title":"Nat. Commun."},{"key":"6513_CR28","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1523\/JNEUROSCI.1291-17.2018","volume":"38","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. Sox2 is essential for oligodendroglial proliferation and differentiation during postnatal brain myelination and CNS remyelination. J. Neurosci. 38, 1802\u20131820 (2018).","journal-title":"J. Neurosci."},{"key":"6513_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1242\/dev.098418","volume":"141","author":"SA Hoffmann","year":"2014","unstructured":"Hoffmann, S. A. et al. Stem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytes. Development 141, 39\u201350 (2014).","journal-title":"Development"},{"key":"6513_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI28844","volume":"117","author":"\u00c2A Chora","year":"2007","unstructured":"Chora, \u00c2. A. et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest 117, 438\u2013447 (2007).","journal-title":"J. Clin. Invest"},{"key":"6513_CR31","doi-asserted-by":"publisher","first-page":"e17727","DOI":"10.1371\/journal.pone.0017727","volume":"6","author":"MD Binder","year":"2011","unstructured":"Binder, M. D. et al. Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination. PLoS One 6, e17727 (2011).","journal-title":"PLoS One"},{"key":"6513_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/glia.23096","volume":"65","author":"T Shimizu","year":"2016","unstructured":"Shimizu, T. et al. YAP functions as a mechanotransducer in oligodendrocyte morphogenesis and maturation. Glia 65, 360\u2013374 (2016).","journal-title":"Glia"},{"key":"6513_CR33","doi-asserted-by":"publisher","first-page":"e1005853","DOI":"10.1371\/journal.pgen.1005853","volume":"12","author":"MD Binder","year":"2016","unstructured":"Binder, M. D. et al. Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status. PLoS Genet 12, e1005853 (2016).","journal-title":"PLoS Genet"},{"key":"6513_CR34","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/hmg\/ddy001","volume":"27","author":"T James","year":"2018","unstructured":"James, T. et al. Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients. Hum. Mol. Genet 27, 912\u2013928 (2018).","journal-title":"Hum. Mol. Genet"},{"key":"6513_CR35","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nm.3618","volume":"20","author":"F Mei","year":"2014","unstructured":"Mei, F. et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat. Med. 20, 954\u2013960 (2014).","journal-title":"Nat. Med."},{"key":"6513_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12647","volume":"502","author":"VA Deshmukh","year":"2013","unstructured":"Deshmukh, V. A. et al. A regenerative approach to the treatment of multiple sclerosis. Nature 502, 327\u2013332 (2013).","journal-title":"Nature"},{"key":"6513_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature14335","volume":"522","author":"FJ Najm","year":"2015","unstructured":"Najm, F. J. et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature 522, 216\u2013220 (2015).","journal-title":"Nature"},{"key":"6513_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11312","volume":"7","author":"MB Keough","year":"2016","unstructured":"Keough, M. B. et al. An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination. Nat. Commun. 7, 11312 (2016).","journal-title":"Nat. Commun."},{"key":"6513_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1056\/NEJMoa010994","volume":"346","author":"A Chang","year":"2002","unstructured":"Chang, A., Tourtellotte, W. W., Rudick, R. & Trapp, B. D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med 346, 165\u2013173 (2002).","journal-title":"N. Engl. J. Med"},{"key":"6513_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1471-4159.2003.01674.x","volume":"85","author":"K Wosik","year":"2003","unstructured":"Wosik, K. et al. Oligodendrocyte injury in multiple sclerosis: a role for p53. J. Neurochem 85, 635\u2013644 (2003).","journal-title":"J. Neurochem"},{"key":"6513_CR41","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.4161\/cc.8.9.8362","volume":"8","author":"M Sachdeva","year":"2009","unstructured":"Sachdeva, M. & Mo, Y. Y. p53 and c-myc: how does the cell balance \u201cyin\u201d and \u201cyang\u201d? Cell Cycle 8, 1303 (2009).","journal-title":"Cell Cycle"},{"key":"6513_CR42","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000550","volume":"6","author":"JA Benjamins","year":"2019","unstructured":"Benjamins, J. A. et al. Exosome-enriched fractions from MS B cells induce oligodendrocyte death. Neurol. - Neuroimmunol. Neuroinflamm. 6, e550 (2019).","journal-title":"Neurol. - Neuroimmunol. Neuroinflamm."},{"key":"6513_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/glia.22606","volume":"62","author":"AD Pusic","year":"2014","unstructured":"Pusic, A. D. & Kraig, R. P. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination. Glia 62, 284\u2013299 (2014).","journal-title":"Glia"},{"key":"6513_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/glia.22743","volume":"63","author":"CY Wang","year":"2015","unstructured":"Wang, C. Y., Yang, S. H. & Tzeng, S. F. MicroRNA-145 as one negative regulator of astrogliosis. Glia 63, 194\u2013205 (2015).","journal-title":"Glia"},{"key":"6513_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainres.2011.01.067","volume":"1383","author":"HY Zhang","year":"2011","unstructured":"Zhang, H. Y. et al. MicroRNAs 144, 145, and 214 are down-regulated in primary neurons responding to sciatic nerve transection. Brain Res 1383, 62\u201370 (2011).","journal-title":"Brain Res"},{"key":"6513_CR46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4049\/jimmunol.1301397","volume":"192","author":"W Su","year":"2014","unstructured":"Su, W. et al. The p53 transcription factor modulates microglia behavior through MicroRNA-dependent regulation of c-Maf. J. Immunol. 192, 358\u2013366 (2014).","journal-title":"J. Immunol."},{"key":"6513_CR47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292\u2013302 (2011).","journal-title":"Ann. Neurol."},{"key":"6513_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41423-018-0198-5","volume":"16","author":"T Dhaeze","year":"2019","unstructured":"Dhaeze, T. et al. CD70 defines a subset of proinflammatory and CNS-pathogenic TH1\/TH17 lymphocytes and is overexpressed in multiple sclerosis. Cell Mol. Immunol. 16, 652\u2013665 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"6513_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann, T. et al. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 133, 13\u201324 (2017).","journal-title":"Acta Neuropathol."},{"key":"6513_CR50","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1101\/gad.1842409","volume":"23","author":"M Xin","year":"2009","unstructured":"Xin, M. et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166\u20132178 (2009).","journal-title":"Genes Dev."},{"key":"6513_CR51","first-page":"3324","volume":"21","author":"RW O\u2019Meara","year":"2011","unstructured":"O\u2019Meara, R. W., Ryan, S. D., Colognato, H. & Kothary, R. Derivation of enriched oligodendrocyte cultures and oligodendrocyte\/neuron myelinating co-cultures from post-natal murine tissues. J. Vis. Exp. 21, 3324 (2011).","journal-title":"J. Vis. Exp."},{"key":"6513_CR52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1460-9568.1995.tb01115.x","volume":"7","author":"M Jung","year":"1995","unstructured":"Jung, M. et al. Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur. J. Neurosci. 7, 1245\u20131265 (1995).","journal-title":"Eur. J. Neurosci."},{"key":"6513_CR53","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/nprot.2007.149","volume":"2","author":"Y Chen","year":"2007","unstructured":"Chen, Y. et al. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat. Protoc. 2, 1044\u20131051 (2007).","journal-title":"Nat. Protoc."},{"key":"6513_CR54","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ab.2011.05.015","volume":"416","author":"KK Biggar","year":"2011","unstructured":"Biggar, K. K., Kornfeld, S. F. & Storey, K. B. Amplification and sequencing of mature microRNAs in uncharacterized animal models using stem-loop reverse transcription-polymerase chain reaction. Anal. Biochem 416, 231\u2013233 (2011).","journal-title":"Anal. Biochem"},{"key":"6513_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"6513_CR56","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550\u2013558 (2014).","journal-title":"Genome Biol."},{"key":"6513_CR57","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084\u20132092 (2019).","journal-title":"Bioinformatics"},{"key":"6513_CR58","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere, U. et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191\u2013w198 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06513-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06513-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06513-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T13:04:52Z","timestamp":1720098292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06513-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6513"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06513-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"23 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"813"}}